Evolva A/S

16 articles about Evolva A/S

• Evolva Business Update

  11/9/2018

  Evolva today provides a quarterly business update, showing a strong underlying dynamic in building the business.

• Evolva Announces Oliver Walker to Succeed Simon Waddington as CEO

  7/10/2018

  Evolva announces that, as part of entering the next phase of its evolution, the current Evolva CEO Simon Waddington steps down as CEO with immediate effect.

• Evolva Provides 2017 Financial Results and Business Highlights

  3/20/2018

  Evolva posted its financial results today for the period from 1 January to 31 December 2017, and provided business highlights that illustrate how the Company is executing on its strategic transformation plan which was put in place last August.

• Evolva Awarded Contract By U.S. Government To Advance Novel Pest Control Product

  9/11/2017

• Neil Goldsmith Stepping Down As CEO And Board Member Of Evolva

  7/7/2017

• Scott Fabro To Join Evolva As Chief Commercial Officer

  6/12/2017

• Evolva Announces Long-Term Commercial Agreement With Cargill Incorporated

  4/3/2017

• Pivotal Evolva Stevia Sweetener Patent Receives U.S. Notice Of Allowance

  12/19/2016

• ERS Genomics And Evolva Sign License Agreement On CRISPR-Cas9 Genome Editing Patents For Industrial Applications

  10/27/2016

• Evolva Enters Partnership On Active Pharmaceutical Ingredients

  8/18/2016

• Evolva’s Nootkatone Enters NIH-Sponsored Studies To Assess Its Effectiveness Against Mosquitoes That Transmit Zika Virus

  7/25/2016

• Evolva A/S To Co-Develop Next-Generation Materials With U.S. Navy

  4/11/2016

• Evolva A/S Expanding Its Nootkatone Research To Include Mosquitos That Transmit Zika And Other Viruses

  3/24/2016

• Evolva A/S And Valent BioSciences Corporation To Co-Develop Agricultural Bioactives

  3/26/2015

• Evolva A/S Unloads EV-035 Series To Emergent BioSolutions For $70.5 Million Plus

  12/17/2014

• Evolva A/S to Receive First Milestone Payment from Roche

  6/14/2011